External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.

Saved in:
Bibliographic Details
Title: External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Authors: Wang Y; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Giardiello D; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Eurac Research, Institute of Biomedicine, Epidemiology and Biostatistics, Bolzano, Italy., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Koop EA; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Opdam M; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Sonke GS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Stathonikos N; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., van der Wall E; Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, the Netherlands., van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands., Linn SC; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Dackus GMHE; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: g.dackus@nki.nl., Schmidt MK; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: mk.schmidt@nki.nl.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113401. Date of Electronic Publication: 2023 Oct 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2023.113401